| Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the ARISTOTLE trial PO Guimarães, SD Pokorney, RD Lopes, DM Wojdyla, BJ Gersh, ... Clinical Cardiology 42 (5), 568-571, 2019 | 99 | 2019 |
| Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trial CSP Lam, A Giczewska, K Sliwa, F Edelmann, J Refsgaard, E Bocchi, ... JAMA cardiology 6 (6), 706-712, 2021 | 64 | 2021 |
| Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial TD Bahnson, A Giczewska, DB Mark, AM Russo, KH Monahan, ... Circulation 145 (11), 796-804, 2022 | 59 | 2022 |
| Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial AM Russo, EP Zeitler, A Giczewska, AP Silverstein, HR Al-Khalidi, ... Circulation 143 (7), 661-672, 2021 | 49 | 2021 |
| Clinical and pharmacological effects of apixaban dose adjustment in the ARISTOTLE trial M Zeitouni, A Giczewska, RD Lopes, DM Wojdyla, C Christersson, ... Journal of the American College of Cardiology 75 (10), 1145-1155, 2020 | 36 | 2020 |
| Spironolactone in acute heart failure patients with renal dysfunction and risk factors for diuretic resistance: from the ATHENA-HF trial SJ Greene, GM Felker, A Giczewska, AP Kalogeropoulos, AP Ambrosy, ... Canadian Journal of Cardiology 35 (9), 1097-1105, 2019 | 25 | 2019 |
| Long-term outcomes of phenoclusters in severe tricuspid regurgitation VN Rao, A Giczewska, K Chiswell, GM Felker, A Wang, DD Glower, ... European Heart Journal 44 (21), 1910-1923, 2023 | 14 | 2023 |
| Prevalence and predictors of no-shows to physical therapy for musculoskeletal conditions NA Bhavsar, SM Doerfler, A Giczewska, B Alhanti, A Lutz, CA Thigpen, ... PLoS One 16 (5), e0251336, 2021 | 14 | 2021 |
| Ultrafiltration in acute heart failure: implications of ejection fraction and early response to treatment from CARRESS‐HF M Fudim, J Brooksbank, A Giczewska, SJ Greene, JL Grodin, P Martens, ... Journal of the American Heart Association 9 (24), e015752, 2020 | 14 | 2020 |
| An assessment of health status and health behaviours in adolescents: main points and methods of the SOPKARD-Junior programme K Suligowska, P Czarniak, M Krawczyk, P Szcześniak, E Król, A Kusiak, ... Archives of Medical Science 14 (1), 38-51, 2018 | 11 | 2018 |
| Big data significance in remote medical diagnostics based on deep learning techniques A Kwaśniewska, A Giczewska, J Rumiński Task Quarterly 21, 309-319, 2017 | 5 | 2017 |
| Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) TME Davis, A Giczewska, Y Lokhnygina, RJ Mentz, N Sattar, RR Holman, ... Cardiovascular Diabetology 21 (1), 116, 2022 | 4 | 2022 |
| Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus CE Barbery, A Giczewska, J White, Y Lokhnygina, RJ Mentz, RR Holman, ... American heart journal 239, 59-63, 2021 | 4 | 2021 |
| Electrocardiographic parameters associated with pacemaker induced cardiomyopathy Z Loring, A Giczewska, P Hofmann, K Chiswell, TT Schlegel, M Ugander, ... Journal of Electrocardiology 77, 17-22, 2023 | 3 | 2023 |
| Predicting Recurrent Care Seeking of Physical Therapy for Musculoskeletal Pain Conditions SZ George, A Giczewska, B Alhanti, AD Lutz, E Shanley, CA Thigpen, ... Pain Medicine 22 (8), 1837-1849, 2021 | 3 | 2021 |
| Using wearable device for biomedical signal acquisition and processing T Kocejko, A Poliński, A Giczewska, J Wtorek 2017 10th International Conference on Human System Interactions (HSI), 6-11, 2017 | 2 | 2017 |
| Relationship between body weight and pharmacokinetics of apixaban in patients with atrial fibrillation: insights from the ARISTOTLE trial J Harrington, A Giczewska, D Wojdyla, JB Washam, M Fudim, Z Hijazi, ... Circulation 144 (Suppl_1), A9290-A9290, 2021 | 1 | 2021 |
| Index Event, Clinical Outcomes and Response to Vericiguat in the Victoria Trial C Lam, KS Sliwa, A Giczewska, K Anstrom, F Edelmann, J Refsgaard, ... Circulation 142 (Suppl_3), A13829-A13829, 2020 | 1 | 2020 |
| Copeptin levels in acute heart failure are associated with a higher risk phenotype, but not diuretic response S Babroudi, W McCallum, A Giczewska, PQ Pinzon, MA Konstam, ... Journal of the American College of Cardiology 75 (11_Supplement_1), 896-896, 2020 | 1 | 2020 |
| Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? insights from post-hoc analysis of EXSCEL KM Gooding, S Stevens, Y Lokhnygina, A Giczewska, AC Shore, ... Diabetes Research and Clinical Practice, 111685, 2024 | | 2024 |
